Iterations in stent technologies, advances in pharmacotherapy, and awareness of the
implications of implantation techniques have markedly reduced the risk of stent failure, both …

Drug-eluting stents (DES) demonstrated superior efficacy when compared to bare metal
stents and plain-old balloon angioplasty and are nowadays used in almost all percutaneous …

Cardiovascular diseases (CVDs) are a leading cause of morbidity and mortality worldwide.
While the application of vascular stents has significantly improved the management of …

In patients undergoing percutaneous coronary intervention, the second-generation drug-
eluting stents (DES) are considered the gold standard of care for revascularization. By …

Cardiovascular diseases (CVD) are the leading global threat to human health. The clinical
application of vascular stents improved the survival rates and quality of life for patients with …

Atherosclerosis is a leading cause of morbidity and mortality worldwide, driven by a complex
interplay of lipid dysregulation, inflammation, and vascular pathology. Despite …

Background: Several studies have reported some sex differences in patients with coronary
artery diseases. However, the results regarding long-term outcomes in patients with chronic …

Cardiovascular diseases are the leading cause of death and current treatments such as
stents still suffer from disadvantages. Balloon expansion causes damage to the arterial wall …

Given the risks of poor patient compliance and bleeding associated with current dual
antiplatelet therapies, it is urgent to develop the next generation of cardiovascular stents with …

Acute coronary syndrome (ACS) stands as a leading global cause of mortality, underscoring
the importance of effective prevention, early diagnosis, and timely intervention. While …